Navigation Links
Boston University School of Medicine researcher recipient of Memory Ride Grant

Boston Newton resident Benjamin Wolozin, MD, PhD, a professor of pharmacology at Boston University School of Medicine, was one of nine Massachusetts researchers to receive a 2007 Memory Ride Grant from the Alzheimers Association. Wolozin received a three-year investigator-initiated research grant for nearly $240,000 to study LRRK2 interactions with pathways linked to protein folding and degradation.

The LRRK2 gene provides instructions for making a protein called dardarin. The LRRK2 gene is active in the brain and other tissues throughout the body, but little is known about this gene or the dardarin protein. Mutations in LRRK2 are the most common genetic cause of Parkinsons Disease. Disease-related mutations in LRRK2 occur at many sites. The prevalence of LRRK2 mutations among subjects with Parkinsons Disease combined with the relevance to multiple types of pathologies emphasizes the importance of LRRK2, according to Wolozin.

Understanding the biology of LRRK2 will provide insight into pathological processes and novel therapeutic approaches for a broad range of neurodegenerative diseases, said Wolozin.

Wolozin serves as the primary investigator for several studies at the Boston University Alzheimers Disease Center. His interests focus on the pathophysiology of Alzheimers and Parkinsons diseases.


Contact: Michelle Roberts
Boston University

Page: 1

Related medicine news :

1. Measles Outbreak in Boston
2. Boston: Best Place For Having a Baby
3. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
4. Researchers at Cornell University as been reported using research fund by false claims
5. A new study by John Hopkins University proposes formula for good health
6. James Cook University urges more medical seats
7. Pill splitting program of University of Michigan can save money
8. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
9. Yale University guidelines for Physicians and Pharmaceutical industry
10. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
11. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ... ... Inevitably when people think Thanksgiving, they also think Holiday sales and start ... and Cyber Monday massage chair sales to receive the best pricing on ... find the best massage chair deals, they can see all of the coupons in ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
Breaking Medicine Technology: